Stanford Cancer Institute Directory
Showing 271 - 280 of 457
Professor of Radiology (General Radiology) at the Stanford University Medical Center
Tarik Massoud is a Professor of Neuroradiology and Molecular Imaging in the Department of Radiology, Stanford University School of Medicine, where he directs LEMNI (the Laboratory of Experimental and Molecular Neuroimaging), and is an Attending Neuroradiologist in Stanford Health Care. He qualified from the Medical School of the Royal College of Surgeons in Ireland and then served as intern to two inspirational medical giants of their days, Dr. William H. (Willie) Bisset at the Royal Hospital for Sick Children in Edinburgh, UK, and Professor Sir Raymond (Bill) Hoffenberg, PRCP, at the Queen Elizabeth Hospital in Birmingham, UK. He trained in Radiology and Neuroradiology in Oxford, UCLA, and the University of Michigan, and is a Fellow of the Royal College of Radiologists in London. He holds a research MD degree (NUI) in experimental neuroimaging (work conducted at UCLA), and a Cambridge PhD in molecular imaging (work conducted at the Crump Institute for Molecular Imaging at UCLA, and the Molecular Imaging Program at Stanford, Gambhir laboratory). From 2000 to 2013 he was a University Lecturer and Honorary Consultant in Neuroradiology at the University of Cambridge School of Clinical Medicine and Addenbrooke’s Hospital in Cambridge, UK. He was formerly an Assistant and Associate Professor of Radiology at UCLA, and held visiting Associate Professorships at Columbia and MCW, Milwaukee. He has published extensively and won numerous awards at scientific meetings. His papers in experimental interventional neuroradiology and molecular imaging are widely cited. He has been a peer reviewer for dozens of international medical journals, as well as other medical charities and governmental funding agencies. He is Editor-in-Chief of the journal Reports in Medical Imaging, and an editorial board member for numerous biomedical journals. In 2016 he was awarded a Special Faculty Permit ('eminent physician license') by the Medical Board of the State of California.
Professor of Microbiology and Immunology
For complete and up to date information on this and other items, consult my Curriculum vitae (updated, 12/16), and website; URL: http://www.stanford.edu/~amatin/MatinLabHomePage/MatinLabHome-Page.htm
Assistant Professor of Radiation Oncology (Radiation Physics) at the Stanford University Medical Center
Dr. Maxim is a medical physicist in Radiation Oncology at Stanford University and Biophysicist, whose personal vision is the development of advanced, curative radiation therapy for all types and stages of malignancies, and new indications such as cardiovascular illnesses that will lead to increased survival worldwide from the top cancer and non-cancer causes of mortality. His personal areas of emphasis are stereotactic ablative radiation therapy (SABR), four-dimensional computed tomography (4D CT), and the development of novel, and safe radiation therapy that addresses the major technical challenge of accurately and precisely treating moving targets and anatomy. Peter is interested in the management of interdisciplinary, science and technology oriented teams in health care and is actively developing next generation radiotherapy technologies. Peter received his Dipl. Phys. (M.Sc.) from the Technical University, Berlin, Germany his Dr. rer. nat. (PhD) from Humboldt University, Berlin, Germany. He is certified by the American Board of Radiology in Therapeutic Radiologic Physics. He is currently an Assistant Professor of Radiation Oncology at Stanford University.
Associate Professor of Medicine (Hematology) at the Stanford University Medical Center
Bruno C. Medeiros, MD is associate professor of medicine and director of the inpatient hematology service. He is also director of Cancer Center ITA services at Stanford Comprehensive Cancer Center. Dr. Medeiros graduated from the Universidade Federal do Parana with a medical degree, in 1998. He completed his post-graduate training at the University of Colorado in Denver and the Princess Margaret Hospital in Toronto (Acute leukemia fellowship). Dr. Medeiros’ clinical interests include management of advanced hematologic malignancies, including AML, ALL, MDS and CML. His clinical research interest focuses on the development of novel therapeutic regimens for patients with acute leukemia, with special interest in the development of novel therapeutic strategies for patients with acute myeloid leukemia. He is the leader in several institutional investigator initiated clinical trials, active investigator in collaborative multi-institutional clinical studies and an active member of the SWOG acute leukemia panel. Dr. Medeiros has authored more than 120 peer-reviewed manuscripts. Dr. Medeiros has served as the track leader for ASCO meeting Leukemia, Myelodysplasia and Transplantation scientific review subcommittee, he functions as the Associate Editor of the Leukemia Panel for Cancer.Net, he is a member of the editorial board for Leukemia Research and serves as a reviewer for several specialized journals, such as Blood, Leukemia, Haematologica and Cancer, among others.
Assistant Professor of Otolaryngology/Head and Neck Surgery (Comprehensive ENT) at the Stanford University Medical Center
Dr. Megwalu was born in Ottawa, Ontario, Canada, but spent most of his childhood in Nigeria. He received his undergraduate degree from McMaster University in Hamilton, Ontario, Canada. Dr. Megwalu received his medical degree from Washington University School of Medicine, completed his residency at New York Eye and Ear Infirmary, and received his MPH degree from Icahn School of Medicine at Mount Sinai. After residency, Dr. Megwalu joined the faculty at Icahn School of Medicine at Mount Sinai, where he served as Director of Otolaryngology at Queens Hospital Center, and Assistant Regional Director of Otolaryngology for Queens Health Network from 2011 to 2015. Dr. Megwalu Joined the Division of Comprehensive Otolaryngology at Stanford in 2016. His clinical interests include thyroid and parathyroid disorders, head and neck tumors, sinusitis, and chronic ear disorders. Dr. Megwalu conducts outcomes/health services research, with a focus on health literacy, health disparities, and comparative effectiveness research.
Assistant Professor of Pathology at the Stanford University Medical Center
Dr. Merker is a clinical laboratory-based physician who specializes in genetic disease testing for both heritable disease and cancer. He is board-certified in Molecular Genetic Pathology, Clinical Pathology, and Clinical Cytogenetics. Dr. Merker is Co-Director of the Stanford Medicine Clinical Genomics Service, a laboratory section within the Stanford Anatomic Pathology & Clinical Laboratories that uses genomic sequencing and other advanced methods to evaluate the cause of disease in patients with unexplained heritable disease. He also directs an active research group that focuses on two areas: 1) development of improved experimental and computational approaches related to the use of genomic sequencing and other “omics” assays for clinical care, and 2) identification and characterization of acquired and heritable genetic variants that are important for the development of hematologic disorders and other malignancies.
Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Research focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.